Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug

Interrupted course of antitumor necrosis factor alpha therapy versus combined nonsteroidal anti-inflammatory drug therapy and physiotherapy in patients with ankylosing spondylitis: A comparative study Abdelrahman SK, M. Mostafa TF - J Med

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry - Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee

Table IV from Assessment of ankylosing spondylitis.

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Clinical Tools to Assess and Monitor Spondyloarthritis

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing

Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis – topic of research paper in Clinical medicine.

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

Ankylosing spondilitis

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study, BMC Musculoskeletal Disorders

Percentage of patients achieving Ankylosing Spondylitis Disease

PDF) The Value of the Ankylosing Spondylitis Disease Activity Score (Asdas) in Evaluating Disease Activity in Patients with Axial Spondyloarthritis

Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis